Open AccessA CRISPR/dCasX‐mediated transcriptional programming system for inhibiting the progression of bladder cancer cells by repressing c‐MYC or activating TP53
Author(s) -
Cao Congcong,
Yao Lin,
Li Aolin,
Zhang Quan,
Zhang Zhenan,
Wang Xiaofei,
Gan Ying,
Liu Yuchen,
Zhang Qian
Publication year - 2021
Publication title -
clinical and translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 1
ISSN - 2001-1326
DOI - 10.1002/ctm2.537
Subject(s) - crispr , cancer research , bladder cancer , cancer , medicine , biology , gene , genetics